G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,000 | -26.7% | 2,920 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $30,000 | -23.1% | 2,920 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $39,000 | -39.1% | 2,920 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $64,000 | -8.6% | 2,920 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $70,000 | +32.1% | 2,920 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $53,000 | +55.9% | 2,920 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $34,000 | -52.1% | 2,920 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $71,000 | +121.9% | 2,920 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $32,000 | -58.4% | 2,920 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $77,000 | +14.9% | 2,920 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $67,000 | -25.6% | 2,920 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $90,000 | +233.3% | 2,920 | +80.5% | 0.00% | +300.0% |
| Q1 2019 | $27,000 | -12.9% | 1,618 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $31,000 | -63.5% | 1,618 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $85,000 | +21.4% | 1,618 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $70,000 | +66.7% | 1,618 | +41.9% | 0.00% | +50.0% |
| Q1 2018 | $42,000 | +223.1% | 1,140 | +70.1% | 0.00% | +100.0% |
| Q4 2017 | $13,000 | – | 670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |